DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ethambutol (Ethambutol Hydrochloride) - Current Clinical Trials


Ethambutol Related Clinical Trials

Effect of Weight and/or Obesity on Ethambutol Drug Concentrations [Completed]

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [Completed]

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [Completed]

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients [Completed]

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS [Completed]

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [Completed]

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis [Recruiting]

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis [Completed]

Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography [Completed]

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults [Completed]

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [Completed]

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis [Recruiting]

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB [Not yet recruiting]

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation [Recruiting]

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [Completed]

Improving Retreatment Success (IMPRESS) [Recruiting]

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [Completed]

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [Completed]

Early Bactericidal Activity (EBA) Study of Tuberculosis Regimens With and Without INH and Moxifloxacin [Recruiting]

Research on New Regimens for Retreatment Pulmonary Tuberculosis [Recruiting]

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB [Active, not recruiting]

TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance [Completed]

Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis [Recruiting]

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Active, not recruiting]

Tuberculosis Treatment Shortening Trial [Completed]

PK Study of Anti-TB Drugs [Not yet recruiting]

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment [Completed]

Latency in Pulmonary Tuberculosis [Recruiting]

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 [Recruiting]

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis [Active, not recruiting]

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment [Active, not recruiting]

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis [Completed]

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes [Recruiting]

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis [Completed]

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Active, not recruiting]

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [Completed]

The Treatment of Tuberculosis in HIV-Infected Patients [Completed]

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [Completed]

Shortening Treatment by Advancing Novel Drugs [Recruiting]

Assessing PA-824 for Tuberculosis (the APT Trial) [Recruiting]

Preventive Therapy for Tuberculosis in HIV Infected Persons [Active, not recruiting]

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Completed]

Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis [Completed]

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens [Not yet recruiting]

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Recruiting]

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Completed]

A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. [Recruiting]

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [Completed]

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [Completed]

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [Completed]

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease [Recruiting]

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Completed]

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana [Recruiting]

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) [Recruiting]

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV [Recruiting]

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan [Active, not recruiting]

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study [Recruiting]

HRZE Fasted/Fed in Newly Diagnosed TB [Completed]

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) [Completed]

Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou [Recruiting]

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections [Completed]

Treatment of Mycobacterium Xenopi Pulmonary Infection [Recruiting]

Study of Daily Rifapentine for Pulmonary Tuberculosis [Completed]

Use of Azithromycin and Rifabutin Administered Three Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease [Active, not recruiting]

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Recruiting]

Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs [Recruiting]

Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis [Completed]

Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients [Recruiting]

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection [Not yet recruiting]

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy [Recruiting]

Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis [Completed]

Optimization of the TB Treatment Regimen Cascade [Recruiting]

Trial of Antimycobacterial Therapy in Sarcoidosis [Active, not recruiting]

Phase 2a EBA Trial of AZD5847 [Completed]

A Study Of PNU-100480 In Newly Diagnosed, Treatment Sensitive Patients With Pulmonary Tuberculosis To Assess Early Bactericidal Activity (EBA) And Whole Blood Activity (WBA) [Completed]

Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study [Completed]

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) [Recruiting]

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients [Completed]

Trial of High-Dose Rifampin in Patients With TB [Active, not recruiting]

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017